TFBS Bioscience (ROCO:6939) Total Current Liabilities: NT$200.3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6939 TFBS Bioscience Inc ROCO:6939
49 GF Score
Price NT$20.50
GF Value NT$32.08
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is TFBS Bioscience Total Current Liabilities?

TFBS Bioscience ROCO:6939 49 Total Current Liabilities is NT$200.3 Mil as of Dec. 2025. GuruFocus rates ROCO:6939 with a GF Score™ of 49/100 and a GF Value™ of NT$32.08 (Possible Value Trap). The stock has 6 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. TFBS Bioscience's total current liabilities for the quarter that ended in Dec. 2025 was NT$200.3

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

TFBS Bioscience Total Current Liabilities Related Terms

TFBS Bioscience Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for TFBS Bioscience's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFBS Bioscience Total Current Liabilities Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial 50.45 103.81 84.88 188.75 200.30

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.88 88.09 188.75 264.07 200.30
ROCO:6939
49GF Score
TFBS Bioscience Inc ROCO:6939
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TFBS Bioscience Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

TFBS Bioscience's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=41.456+130.664
+Other Current Liabilities+Current Deferred Liabilities
=28.176+0
=200.3

TFBS Bioscience's Total Current Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=41.456+130.664
+Other Current Liabilities+Current Deferred Liabilities
=28.176+0
=200.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of NT$200.3 Mil mean?
TFBS Bioscience (ROCO:6939) has a Total Current Liabilities of NT$200.3 Mil as of Dec. 2025. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for TFBS Bioscience and its competitors.
Is TFBS Bioscience's Total Current Liabilities too high?
TFBS Bioscience's current Total Current Liabilities is NT$200.3 Mil. Overall, TFBS Bioscience has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's Total Current Liabilities compare to TMO and DHR?
TFBS Bioscience's Total Current Liabilities of NT$200.3 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Medical Diagnostics & Research company?
A good Total Current Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for TFBS Bioscience and its competitors. TFBS Bioscience's current Total Current Liabilities is NT$200.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$32.08, compared to a current price of NT$20.50 — trading 36.1% below its estimated fair value. The current Total Current Liabilities is NT$200.3 Mil. TFBS Bioscience's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current Total Current Liabilities is NT$200.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?

Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued. The current stock price of NT$20.50 is trading 36.1% below its estimated GF Value™ of NT$32.08. GuruFocus considers TFBS Bioscience to be Possible Value Trap.

Key valuation signals for ROCO:6939:

  • Total Current Liabilities: NT$200.3 Mil
  • GF Value™: NT$32.08 vs. price of NT$20.50 (36.1% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TFBS Bioscience Business Description

Address No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
49GF Score

Get the complete analysis for ROCO:6939

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.50
Price
NT$32.08
GF Value